Dopamine transporter and D2-receptor density in late-onset alcoholism

被引:0
|
作者
E. Repo
Jyrki T. Kuikka
Kim A. Bergström
Jari Karhu
Jukka Hiltunen
Jari Tiihonen
J. Kuikka
机构
[1] Department of Forensic Psychiatry,
[2] University of Kuopio,undefined
[3] Niuvanniemi Hospital,undefined
[4] FIN-70240 Kuopio,undefined
[5] Finland e-mail: eila.repo@niuva.fi,undefined
[6] Fax: +358-17-203-494,undefined
[7] Department of Clinical Physiology,undefined
[8] Kuopio University Hospital,undefined
[9] P.O. Box 1777,undefined
[10] FIN-70211 Kuopio,undefined
[11] Finland,undefined
[12] Department of Clinical Neurophysiology,undefined
[13] Kuopio University Hospital,undefined
[14] P.O. Box 1777,undefined
[15] FIN-70211 Kuopio,undefined
[16] Finland,undefined
[17] Map Medical Technologies Oy,undefined
[18] Elementtitie 27,undefined
[19] FIN-41160 Tikkakoski,undefined
[20] Finland,undefined
来源
Psychopharmacology | 1999年 / 147卷
关键词
Key words Alcoholism; Dopamine transporter; [123I]PE2I; [123I]Epidepride; SPECT;
D O I
暂无
中图分类号
学科分类号
摘要
Rationale: Late onset type 1 alcoholism has been suggested to be associated with an underlying dopaminergic defect. Therefore, it is relevant to study both postsynaptic D2-receptor and presynaptic dopamine transporter (DAT) densities among alcoholics. Objective: We investigated DAT densities, along with striatal and extrastriatal dopamine D2-receptor densities, in nine non-violent late-onset male alcoholics, who had no major mental disorder nor antisocial personality disorder (ASPD), and nine healthy controls. Methods: [123I]PE2I and [123I]epidepride were used in SPECT imaging. Results: DAT occupancy ratios (striatum/cerebellum) were significantly lower among alcoholics than in controls. Extrastriatal D2-receptor occupancy ratios (temporal pole/cerebellum) were not significantly different between the groups. Conclusions: Striatal presynaptic DAT densities are decreased among type 1 alcoholics, and this finding is not associated with recent alcohol abuse.
引用
收藏
页码:314 / 318
页数:4
相关论文
共 50 条
  • [21] STRIATAL DOPAMINE D2-RECEPTOR BLOCKADE BY TYPICAL AND ATYPICAL NEUROLEPTICS
    BRUCKE, T
    ROTH, J
    PODREKA, I
    STROBL, R
    WENGER, S
    ASENBAUM, S
    LANCET, 1992, 339 (8791): : 497 - 497
  • [22] The possible involvement of the dopamine D2-receptor pathway components in schizophrenia
    Amar, S.
    Shaltiel, G.
    Shamir, A.
    Mann, L.
    Belmaker, R. H.
    Agam, G.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S146 - S146
  • [23] Neuroprotective Mechanisms of Antiparkinsonian Dopamine D2-Receptor Subfamily Agonists
    Yoshihisa Kitamura
    Takashi Taniguchi
    Shun Shimohama
    Akinori Akaike
    Yasuyuki Nomura
    Neurochemical Research, 2003, 28 : 1035 - 1040
  • [24] A simple procedure for synthesis of roxindole, a dopamine D2-receptor agonist
    Csende, F
    ARCHIV DER PHARMAZIE, 2001, 334 (07) : 253 - 254
  • [25] ALCOHOLISM AND THE D2-DOPAMINE RECEPTOR GENE
    NOBLE, EP
    BLUM, K
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (13): : 1547 - 1547
  • [26] THE DOPAMINE D2 RECEPTOR GENE AND ALCOHOLISM
    NOBLE, EP
    BLUM, K
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (20): : 2667 - 2667
  • [27] ASSOCIATION BETWEEN SEVERITY OF ALCOHOLISM AND THE A1-ALLELE OF THE DOPAMINE D2-RECEPTOR GENE TAQI-A RFLP IN JAPANESE
    ARINAMI, T
    ITOKAWA, M
    KOMIYAMA, T
    MITSUSHIO, H
    MORI, H
    MIFUNE, H
    HAMAGUCHI, H
    TORU, M
    BIOLOGICAL PSYCHIATRY, 1993, 33 (02) : 108 - 114
  • [28] Dopamine D2-receptor Antagonist Droperidol Deepens Sevoflurane Anesthesia
    Araki, Ryuhei
    Hayashi, Kazuko
    Sawa, Teiji
    ANESTHESIOLOGY, 2018, 128 (04) : 754 - 763
  • [29] Neuroprotective mechanisms of antiparkinsonian dopamine D2-receptor subfamily agonists
    Kitamura, Y
    Taniguchi, T
    Shimohama, S
    Akaike, A
    Nomura, Y
    NEUROCHEMICAL RESEARCH, 2003, 28 (07) : 1035 - 1040
  • [30] Extrastriatal dopamine D2-receptor availability in social anxiety disorder
    Plaven-Sigray, Pontus
    Hedman, Erik
    Victorsson, Pauliina
    Matheson, Granville J.
    Forsberg, Anton
    Djurfeldt, Diana R.
    Ruck, Christian
    Halldin, Christer
    Lindefors, Nils
    Cervenka, Simon
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 (05) : 462 - 469